Association of primary sclerosing cholangitis and celiac disease: A case report and review of the literature

Digestive Diseases and Sciences

Volumn 49, Issue 3, 2004, Pages 438-443

  Al Osaimi, Abdullah M S ^a   Berg, Carl L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Anti smooth muscle antibodies; Antiendomysial antibodies; Antigliadin antibodies; Celiac disease; HLA; Inflammatory bowel disease; Primary sclerosing cholangitis

Indexed keywords

ANTIPRURITIC AGENT; CORTICOSTEROID; ENDOMYSIUM ANTIBODY; GLIADIN ANTIBODY; HLA ANTIGEN; IRON; SMOOTH MUSCLE ANTIBODY; URSODEOXYCHOLIC ACID;

ADULT; CASE REPORT; CELIAC DISEASE; CLINICAL FEATURE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GLUTEN FREE DIET; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; INTESTINE BIOPSY; LIVER BIOPSY; LIVER FUNCTION TEST; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS;

ANTIBODIES; CELIAC DISEASE; CHOLANGITIS, SCLEROSING; COMORBIDITY; FEMALE; HUMANS; MIDDLE AGED;

EID: 1842556404     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000020499.88546.61     Document Type: Review

References (45)

1. Lee YM, Kaplan MM: Primary sclerosing cholangitis. N Engl J Med 332:924-933, 1995
2. Gillberg R, Dotevall G, Ahren C: Chronic inflammatory bowel dis* ease in patients with celiac disease. Scand J Gastroenterol 17:491-496, 1982
3. Hay JE, Weisner RH, Shorter RG, LaRusso NF, Baldus WP: Primary sclerosing cholangitis and celiac disease: A novel association. Ann Intern Med 109:713-717, 1988
4. Lewis HM, Goldin R, Leonard JN: Dermatitis herpetiformis and primary sclerosing cholangitis. Clin Exp Dermatol 18:363-365, 1993
5. Tysk C: Concurrent ulcerative colitis, celiac sprue, and primary scle* rosing cholangitis. J Clin Gastroenterol 18:241-242, 1994
6. Lacaille F, Canioni D, Bernard O, Fabre M, Brousse N, Schmitz J: Celiac disease, inflammatory colitis, and primary sclerosing cholan* gitis in a girl with Turner's syndrome. J Pediatr Gastroenterol Nutr 21:463-467, 1995
7. Fracassetti O, Delvecchio G, Tambini R, Lorenzi N, Gavazzeni G: Primary sclerosing cholangitis with celiac sprue: two cases. J Clin Gastroenterol 22:71-80, 1996
8. Venturini I, Cosenza R, Miglioli L, Borghi A, Bagni A, Gandolfo M, Modonesi G, Zeneroli ML: Adult celiac disease and primary scleros* ing cholangitis: two case reports. Hepatogastroenterolgy 45:2344-2347, 1998
9. Gow PJ, Fleming KA, Chapman RW: Primary sclerosing cholangitis associated with rheumatoid arthritis and HLA DR4: Is the associa* tion a marker of patients with progressive liver disease? J Hepatol 34:631-635, 2000
10. Kaukinen K, Halme L, Collin P, Farkkila M, Maki M, Vehmanen P, Partanen J, Hockerstedt K: Celiac disease in patients with severe liver disease: Gluten-free diet may reverse hepatic failure. Gastroen* terology 122:881-888, 2002
11. Jacobsen MB, Fausa O, Elgjo K, Schrumpf E: Hepatic lesions in a dult celiac disease. Scand J Gastroenterol 25:656-662, 1990
12. Abdulkarim AS, Wiesner RH, Murray JA, Krause PK: Tissue trans* glutaminase antibodies are frequent in severe chronic liver dis* ease with celiac disease associated HLA type. Gastroenterology 220:A179-A180, 2002 (abstr)
13. Snook JA, de silva HJ, Jewell DP: The association of autoimmune disorders with inflammatory bowel disease. QJM 72:835-840, 1989
14. Olsson R, Danielsson A, Jarnerot G, Lindstrom E, Loof L, Rolny P, Ryden BO, Tysk C, Wallerstedt S: Prevalence of primary scleros* ing cholangitis in patients with ulcerative colitis. Gastroenterology 100:1319-1323, 1991
15. Chapman RW, Varghese Z, Gaul R, Patel G, Kokinon N, Sherlock S: Association of primary sclerosing cholangitis with HLA B8. Gut 24:38-41, 1983
16. Sollid LM, Thorsby E: HLA susceptibility genes in celiac dis* ease: Genetic mapping and role in pathogenesis. Gastroenterology 105:910-922, 1993
17. Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, Ciusani E, Chapman R, Ercilla G, Fausa O, Knutsen I, Pares A, Rosina F, Olerup O, Thorsby E, Schrumpf E: HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 53:459-469, 1999
18. Prochazka EJ, Terasaki PI, Park MS, Goldstein LI, Busuttil RW: Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med 322:1842-1844, 1990
19. Zetterquist H, Broome U, Einarsson K, Oerlup O: HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: No HLA-DRw52a association in Swedish patients with sclerosing cholangitis. Gut 33:942-946, 1992
20. Park MS, Teraski PI: Inability to attribute susceptibility to primary sclerosing cholangitis to specific amino acid positions of the HLA-DRw52a allele [Letter]. N Engl J Med 325:1252, 1991
21. Schrumpf E: Association of primary sclerosing cholangitis and celiac disease: fact or fancy? Hepatology 10:1020-1021, 1989
22. Lanspa SJ, Chan ATH, Bell JS III, Go VLW, Dickson ER, DiMagno EP: pathogenesis of steatorrhea in primary biliary cirrhosis. Hepa* tology 5:837-842, 1985
23. Volta U, Bellentani S, Bianchi FB, Brandi G, De Franceschi L, Miglioli L, Granito A, Balli F, Tiribelli C: High prevalence of celiac disease in Italian general population. Dig Dis Sci 46:1500-1505, 2001
24. Cook HB, Burt MJ, Collett JA, Whitehead MR, Frampton CM, Chapman BA: Adult celiac disease: prevalence and clinical signifi* cance. J Gastroenterol Hepatol 15:1032-1036, 2000
25. Hovell CJ, Collett JA, Vautier G, Cheng AJP, Sutanto E, Mallon DF, Olynyk JK, Cullen DJE: High prevalence of celiac disease in a population-based study from Western Australia: a case for screen* ing? Med J Aust 175:247-250, 2001
26. Rostami K, Mulder CJJ, Werre JM, van Beukelen FR, Kerchhaert J, Crusius JBA, Pena AS, Willekeas FLA, Meijer JWR: High preva* lence of celiac disease in apparently healthy blood donors suggests a high prevalence of undiagnosed celiac disease in the Dutch popu* lation. Scand J Gastroenterol 34:276-279, 1999
27. Hovdenak N, Hovild E, Aksnes L, Fluge G, Erichsen MM, Eide J: High prevalence of asymptomatic celiac disease in Norway: a study of blood donors. Eur J Gastroenterol Hepatol 11:185-187, 1999
28. Not T, Horvath K, Hill ID, Partanen J, Hammed A, Magazzu G, Fasano A: Celiac disease risk in the USA: high prevalence of antien* domysium antibodies in healthy blood donors. Scand J Gastroenterol 33:494-498, 1998
29. James MW, Scott BB: Celiac disease: The cause of the various asso* ciated disorders? Eur J Gastroenterol Hepatol 13:1119-1121, 2001
30. Parnell NDJ, Ciclitira PJ: Review article: Celiac disease and its management. Aliment Pharmacol Ther 13:1-13, 1999
31. Farrell RJ, Kelly CP: Celiac sprue. N Engl J Med 346:180-188, 2002
32. Fasano A, Catassi C: Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 120:636-651, 2001
33. Volta U, Molinaro N, de Franceschi L, Fratangelo D, Bianchi FB: IgA anti-endomysial antibodies on human umbilical cord tissue for celiac disease screening: save both money and monkeys. Dig Dis Sci 40:1902-1905, 1995
34. Ferreira M, Davies SL, Butler M, Scott D, Clark M, Kumar P: En* domysial antibody: is it the best screening test for celiac disease? Gut 33:1633-1637, 1992
35. Grodzinsky E, Hed J, Skogh T: IgA antiendomysium antibodies have a high positive predictive value for celiac disease in asymptomatic patients. Allergy 49:593-597, 1994
36. Lagerqvist C, Ivarsson A, Juto P, Persson LA, Hernell O: Screen* ing for adult celiac disease - Which serological marker(s) to use? J Intern Med 250:241-248, 2001
37. Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BME, Meijer JWR, Mulder CJJ: Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical prac* tice. Am J Gastroenterol 94:888-894, 1999
38. Uibo O, Uibo R, Kleimola V, Jogi T, Maki M: Serum IgA anti* gliadin antibodies in an adult population sample: high prevalence without celiac disease. Dig Dis Sci 38:2034-2037, 1993
39. Catassi C, Fanciulli G, D'Appello AR, El Asmar R, Rondina C, Fabiani E, Bearzi I, Coppa GV: Antiendomysium versus antigliadin antibodies in screening the general population for celiac disease. Scand J Gastroenterol 35:732-736, 2000
40. Sjoberg K, Lindgren S, Eriksson S: Frequent occurrence of non-specific gliadin antibodies in chronic liver disease. Endomysial but not gliadin antibodies predict celiac disease in patients with chronic liver disease. Scand J Gastroenterol 32:1162-1167, 1997
41. Lindgren S, Sjoberg K, Ericksson S: Unsuspected celiac disease in chronic 'cryptogenic' liver disease. Scand J Gastroenterol 29:661-664, 1994
42. Angulo P, Peter JB, Gershwin ME, DeSotel CK, Shoenfeld Y, Ahmed AEE, Lindor KD: Serum autoantibodies in patients with primary sclerosing cholangitis. J Hepatol 32:182-187, 2000
43. Lasagni D, Ferrari R, Lapini M: Unmasking anti-endomysial anti* bodies in celiac subjects positive for anti-smooth muscle antibodies. Acta paediatr 88:462-164, 1999
44. Logan RFA, Ferguson A, Finlayson NDC, Weir DG: Primary bil* iary cirrhosis and celiac disease: An association? Lancet 1:230-233, 1978
45. Olsson R, Kagevi I, Rydberg L: On the occurrence of primary bil* iary cirrhosis and intestinal villous atrophy. Scand J Gastroenterol 17:625-628, 1982